BIIB  valuation analysis

Basics
Name: Biogen Inc
Description: Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. (more)
Industry: Drug Manufacturers-General
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 03, 2022
Market cap: $29.87B (238th)
Sales(TTM): $10.82B (306th)
Earnings(TTM): $1.36B (257th)

Value
FFER: 1.10 (why)
Actual price: $202.36
FFEThis is Biogen Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $183.29
Quantile: BIIB is expensive given its fundamentals.
Prices as of EOD 2022-05-25
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Biogen Inc
"Drug Manufacturers-General" industry
Sales / MarketCap
Biogen Inc
"Drug Manufacturers-General" industry
Book / MarketCap
Biogen Inc
"Drug Manufacturers-General" industry
Equity / Assets
Biogen Inc
"Drug Manufacturers-General" industry